Sirio Pharma Co., Ltd.
SHZ: 300791.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- CEO
- Peiqing Li
- Employees
- 2,610
- Headquarters
- Shantou, China
- IPO year
- 2019
- Market cap
- CN¥5.9B
- Website
- https://www.siriopharm.com
Loading 300791…
Loading profile data…Frequently asked questions about 300791
What does Sirio Pharma Co., Ltd. (300791.SZ) do?
Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplements to customers worldwide. The company develops and manufactures a range of softgel dietary supplements; vegetarian softgel; various nutraceutical gummies; probiotic products; tablet and powder products; capsules; and functional beverages. It also offers a range of s...
Where does 300791.SZ trade?
Sirio Pharma Co., Ltd. (300791.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300791.SZ in?
Sirio Pharma Co., Ltd. (300791.SZ) operates in the Consumer Defensive sector, specifically in the Packaged Foods industry.
Who is the CEO of Sirio Pharma Co., Ltd.?
Peiqing Li is the chief executive officer of Sirio Pharma Co., Ltd. (300791.SZ).
Where is Sirio Pharma Co., Ltd. headquartered?
Sirio Pharma Co., Ltd. is headquartered in China.
Does 300791.SZ pay a dividend?
Yes — Sirio Pharma Co., Ltd. (300791.SZ) paid a trailing twelve-month dividend of CNY 0.50 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300791.SZ go public?
Sirio Pharma Co., Ltd. (300791.SZ) completed its initial public offering in 2019.